Overview
Adenocarcinoma of the prostate is a malignant neoplasm originating in the glandular cells of the prostate gland, commonly diagnosed in older men and often characterized by elevated prostate-specific antigen (PSA) levels 1.Diagnosis
Elevated PSA levels 1.
Digital rectal examination (DRE) abnormalities 1.
Biopsy confirmation through transrectal ultrasound (TRUS) guided needle biopsy 1.
Grading using Gleason score based on biopsy tissue characteristics 1.Management
Radical prostatectomy, including robot-assisted laparoscopic prostatectomy for suitable candidates 1.
Radiation therapy, either external beam or brachytherapy, as an alternative to surgery 1.
Androgen deprivation therapy (ADT) for advanced or metastatic disease, often involving gonadotropin-releasing hormone (GnRH) agonists or antagonists 1.
Active surveillance for low-risk patients with close monitoring 1.Special Populations
No specific details provided regarding management in pregnancy, pediatrics, elderly, or comorbid conditions within the given abstracts 12.Key Recommendations
Utilize validated tools for assessing surgical skills in robot-assisted prostatectomy to ensure optimal outcomes (Evidence: Expert opinion) 1.
Consider radical prostatectomy or radiation therapy based on patient-specific factors and disease stage (Evidence: Moderate) 1.
Implement active surveillance for low-risk adenocarcinoma of the prostate to minimize overtreatment (Evidence: Moderate) 1.References
1 Goh AC, Goldfarb DW, Sander JC, Miles BJ, Dunkin BJ. Global evaluative assessment of robotic skills: validation of a clinical assessment tool to measure robotic surgical skills. The Journal of urology 2012. link
2 Sekine H, Ohya K, Kojima S, Mizuguchi K. Solitary fibrous tumor of the prostate. International journal of urology : official journal of the Japanese Urological Association 2001. link